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Recent studies suggest health benefits including protection from cancer after eating fermented foods such as probiotic yogurt,
though the mechanisms are not well understood. Here we tested mechanistic hypotheses using two different animal models:
the first model studied development of mammary cancer when eating a Westernized diet, and the second studied animals
with a genetic predilection to breast cancer. For the first model, outbred Swiss mice were fed a Westernized chow putting
them at increased risk for development of mammary tumors. In this Westernized diet model, mammary carcinogenesis was
inhibited by routine exposure to Lactobacillus reuteri ATCC-PTA-6475 in drinking water. The second model was FVB strain
erbB2 (HER2) mutant mice, genetically susceptible to mammary tumors mimicking breast cancers in humans, being fed a regu-
lar (non-Westernized) chow diet. We found that oral supplement with these purified lactic acid bacteria alone was sufficient to
inhibit features of mammary neoplasia in both models. The protective mechanism was determined to be microbially-triggered
CD41CD251 lymphocytes. When isolated and transplanted into other subjects, these L. reuteri-stimulated lymphocytes were
sufficient to convey transplantable anti-cancer protection in the cell recipient animals. These data demonstrate that host
immune responses to environmental microbes significantly impact and inhibit cancer progression in distal tissues such as
mammary glands, even in genetically susceptible mice. This leads us to conclude that consuming fermentative microbes such
as L. reuteri may offer a tractable public health approach to help counteract the accumulated dietary and genetic carcinogenic
events integral in the Westernized diet and lifestyle.
Breast cancer is the most prevalent type of cancer in women
worldwide and a leading cause of neoplasia-associated mor-
tality.1 Although genetic predisposition plays a role, accumu-
lating epidemiological and experimental data also link an
unhealthy diet and obesity with postmenopausal mammary
cancer occurrence and growth.1–6 The mechanisms explaining
this connection are largely unknown. Several lines of evi-
dence, however, suggest that inter-related metabolic and
inﬂammatory pathways may be involved. Speciﬁcally, altered
hormonal pathways involving estrogens, insulin and insulin
growth factor, imbalances in the expression of adipokines
such as leptin and adiponectin and obesity-associated proin-
ﬂammatory signaling have all been shown to promote mam-
mary tumorigenesis.1,4–10 Interestingly, data from several
elegant experiments using high-fat diet-fed mice indicate that
obesity-associated inﬂammation could promote mammary
cancer independently from ovarian hormones,8,10 insulin6
and adipokine effects.9 Taken together these data suggest that
immune system-related events may hold the key trigger role
in the complex interplay between growth factors, hormones
and adipokine signaling, which connects diet and obesity
with mammary carcinogenesis.11 Despite the progress made
in identifying the mechanisms underlying the obesity-
mammary cancer associations, the question “how do we
block the adverse effects of obesity on postmenopausal breast
cancer?” has been recently characterized as urgent.11
In an earlier series of experiments we have shown that
inﬂammatory signals from bacteria colonizing the gut can
trigger mammary carcinogenesis in mice.12–14 Speciﬁcally,
anti-inﬂammatory therapies including anti-tumor necrosis
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factor (TNF)-alpha treatments, and adoptive cell transfer
using gut-bacteria-activated regulatory T (Treg) cells are able
to block tumor-promoting effects in both ApcMin/1 and
MMTV-HER2/neu mouse model.12–14 Murine models exhib-
iting mutations in the erbB2 gene are widely used to mimic
neoplastic processes seen in 30% of patients with breast
cancer.15 Interestingly, recent evidence from women with
estrogen-receptor-negative breast cancer shows that tumor-
inﬁltrating Treg are associated with a more favorable clinical
outcome.16
In a more recent series of experiments we discovered that
feeding mice with the edible probiotic bacterium Lactobacillus
reuteri (L. reuteri) exerts unexpected effects in the integument,
namely that L. reuteri-fed mice have radiant fur with increased
anagenic hair follicles.17 In these studies L. reuteri was chosen
due to broad relevancy by colonizing many mammalian spe-
cies, the precedent for L. reuteri to treat or prevent human dis-
eases such as diarrhea in children, the well-established
precedent in scientiﬁc literature using L. reuteri as a model
probiotic organism, that L. reuteri ATCC-PTA-6475 was origi-
nally isolated from human milk, previously demonstrated efﬁ-
cacy in inﬂammatory diseases in mouse models, in particular
this “anti-inﬂammatory” isolate suited our immune system
study goals, and L. reuteri is very easy to cultivate and dose to
animals. In a separate line of experiments we ﬁnd that L. reu-
teri rescues mice from diet-induced obesity and fat pathology
via CD41Foxp31CD251 regulatory T (Treg) cell-associated
immunomodulatory effects.18 Our recent ﬁndings regarding
the effects of L. reuteri upon Treg cells are in line with previ-
ous studies showing that L. reuteri stimulates the development
of host protective regulatory-T cells in vitro as well as in
vivo.19–21 These data taken together with previous evidence
that dietary lactic acid bacteria could lower the risk of breast
cancer in women,22,23 and also suppress mammary cancer
development in mice through immune-system regulatory
events,24–26 led us to test the effects of L. reuteri consumption
in mouse models of mammary cancer.
In the present study, using ﬁrst a high-fat diet-associated
outbred mouse, and then a classical, diet-unrelated genetically
engineered MMTV-HER2/neu mouse model of mammary
cancer, we found that eating puriﬁed lactic acid bacteria
alone was sufﬁcient to delay onset of preneoplastic or neo-
plastic features in both models. The protective mechanism
involved microbially triggered antigen activated CD41CD251
cells that were sufﬁcient to bestow transplantable anti-cancer
protection to recipient host MMTV-HER2/neu mice. These
data demonstrate that host immune responses to environ-
mental microbes signiﬁcantly impact cancer progression in
distal nonintestinal tissues. In these studies, modulation of
the tumor micro-environment by regulating systemic
immune cell responses at the whole organism level was found
to counteract dietary or genetic predisposition to cancer.
Material and Methods
Animals
Outbred CD-1 mice (Charles River; Wilmington, MA), and
inbred MMTV-neu (HER2) FVB strain mice (Jackson Labs,
Bar Harbor, ME), were housed and handled in Association
for Assessment and Accreditation of Laboratory Animal Care
(AAALAC)-accredited facilities with diets, experimental
methods, and housing as speciﬁcally approved by the Institu-
tional Animal Care and Use Committee. The MIT CAC
(IACUC) speciﬁcally approved the studies as well as the
housing and handling of these animals. For studies using out-
bred mice, the experimental design was to expose mice to
diets starting at age5 8 weeks, and then continue the treat-
ment for 12 weeks until euthanasia using carbon dioxide
overdose at 5 months of age, unless otherwise speciﬁed. Each
experiment included 5–15 animals per group with one repli-
cate experiment. Mammary tissues were collected upon
necropsy and then examined histologically.
For experiments using HER2 mice, age-matched female
HER2/neu mutant mice were either untreated or had their
water continuously supplemented with L. reuteri beginning at
8 weeks of age. Mice were euthanized when animals reached
1 year of age, or earlier if the total cumulative tumor burden
on the animal reached 2 cm in diameter. In studies using
adoptive cell transfer, otherwise untreated 6-month-old
female HER2 mice with pre-existing tumor burden where
randomly subdivided into treatment groups that received cell
transplant injections as described in detail below.
Special diets for animals
Outbred Swiss mice were placed on experimental diets start-
ing at 8 weeks of age: control AIN-76A (Harlan–Teklad
Madison WI), and a Westernized diet with high fat and low
ﬁber with substandard levels of Vitamin D (TD.96096; Har-
lan–Teklad), consumed until euthanasia at 20 weeks of age.
In a separate set of studies, FVB strain HER2 transgenic
mice and FVB strain wt cell donor animals received a stand-
ard animal facility mouse chow (Pro Lab RMH 3000; Purina,
Richmond IN).
What’s new?
Can eating fermented foods like yogurt ward off cancer? Recent studies have suggested it’s possible. To find out how, these
authors isolated the probiotic bacteria involved in fermentation and fed them to mice that were susceptible to mammary
tumors. These mice either had genetic changes predisposing them to cancer or were fed a diet known to increase their likeli-
hood of developing the tumors. Eating the lactic acid bacteria stimulated an immune response that delayed the onset of
tumors in both models, suggesting a potential avenue to prevent the cancer in humans.
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Subsets of these Swiss or FVB mice received in their drinking
water an anti-inﬂammatory strain of Lactobacillus reuteri ATCC-
PTA-6475 cultivated as described elsewhere,17,27 with live organ-
isms supplied at a starting dosage of 3.5 3 105 organisms/
mouse/day in drinking water. Live bacterial counts in water bot-
tles were calculated to be 1.4 3 106 colony forming units (CFU)
per mouse after 24 hr, 4.1 3 105 CFU at 48 hr, and 1.1 3 105
CFU at 72 hr, when quantiﬁed as described in detail below. Con-
trol mice received regular drinking water. Fresh drinking water
for both groups of animals was replaced twice weekly throughout
the experiments. Levels of L. reuteri were undetectably low in
untreated animals using PCR as described below.
Confirmation of L. reuteri organisms in drinking water
Lactobacillus reuteri was cultivated as described in previous
studies.17,27 To ascertain counts of live organisms in drinking
water per day, log phase cultures were diluted to 0.05 OD
and 100 mL plated for overnight growth on blood agar plates
(BAP). Overnight cultures were collected into sterile phos-
phate buffered saline (PBS) and the optical density (OD) was
measured. The OD of the preparation was adjusted to 1.0
and measured once again for conﬁrmation. Then 1 mL of
suspension was added to ﬁve separate bottles containing 480
mL of sterile water each and allowed to incubate overnight.
The following morning the contents were mixed by gentle
inversion and 1 mL was diluted 100-fold in sterile water; 50
mL of this dilution were plated at a frequency of 3 BAP per
bottle. Again bottles were allowed to stand overnight and
another 1 mL sample taken from them each, then diluted
100-fold and plated. This process was repeated over 4 days.
Colonies were counted 48 hr after plating due to small col-
ony size. Counts were averaged across and between bottles
per day and number of total CFU in drinking water was
extrapolated based on dilution fold and total water volume.
Confirmation of L. reuteri organisms in experimental
animals
Feces were collected from animals prior to L. reuteri treat-
ment as well as at time of necropsy to gauge its presence
post-treatment in comparison with baseline levels of the bac-
teria. DNA was extracted using the QIAamp DNA Stool
Mini Kit from Qiagen. The extraction was performed as per
the manufacturer’s speciﬁcations with the exemption of an
added fecal dissociation step during the resuspension where
sterile beads were added to the samples and subsequently
placed in a Bullet Blender (New England Biogroup) for more
efﬁcient sample homogenization. L. reuteri speciﬁc quantita-
tive PCRs were performed utilizing primers reported by
Dommels et al.28 on an Applied Biosystems 7500 real-time
PCR machine at a ﬁnal concentration of 0.4 mM each. Assays
were conducted in 25 mL volumes containing 12.5 mL SYBR
Select Master Mix (Applied Biosystems). DNA concentrations
were measured utilizing a Thermo Science Nanodrop 2000C
and 100 ng of DNA were loaded per reaction. Ampliﬁcation
was performed verbatim as previously speciﬁed28 and abso-
lute quantiﬁcations were performed by comparison to a dilu-
tion series (data not shown).
Depletion of CD251 cells
Mice were treated with anti-CD25 antibody (clone PC-61;
Bio- Express, West Lebanon, NH) at 150 lg per mouse intra-
peritoneally 33 weekly for 12 weeks starting a 8-weeks-of-
age. Treated mice were compared to mice receiving sham iso-
type antibody alone. Depletion of CD251 cells was conﬁrmed
by undetectably low fractions of CD251 cells in spleens of
mice treated with anti-CD25 antibody compared to sham-
treated controls using ﬂow cytometry. Depletion was con-
ﬁrmed by absence of Foxp31 cells in spleen.
Adoptive transfer of T cells into recipient mice
CD41 lymphocytes isolated from wild type FVB strain female
mice using magnetic beads (Dynal/Invitrogen; Carlsbad CA)
are sorted by hi-speed ﬂow cytometry (MoFlow2) to ﬁrst
obtain puriﬁed populations of CD41 lymphocytes and deter-
mined to be 96% pure as previously described elsewhere.14
Syngeneic FVB strain MMTV-neu transgenic recipient mice
were then injected intraperitoneally with 3 3 105 CD41
CD45RBloCD251 cells determined to be 96% pure as previ-
ously described elsewhere.14
Histopathology and immunohistochemistry
For histologic evaluation, formalin-ﬁxed tissues were embed-
ded in parafﬁn, cut at 5 lm, and stained with hematoxylin
and eosin. Lesions were analyzed and quantiﬁed by a pathol-
ogist blinded to sample identity. Hyperplastic and preneo-
plastic lesions in the mammary gland of aged Swiss mice
were scored on a 0–6 scale according to the following
scheme: 0: normal; 1: Focal, multifocal or diffuse hyperplasia,
low grade without atypia; 2: Focal, multifocal or diffuse
hyperplasia, intermediate grade without atypia; 3: Focal, mul-
tifocal or diffuse hyperplasia, high grade without atypia; 4:
Focal, multifocal or diffuse hyperplasia with mild atypia; 5:
Focal, multifocal or diffuse hyperplasia with marked atypia;
6: Carcinoma in situ.
Immunohistochemistry (IHC) and morphometric assess-
ment were as previously described.14 IHC-positive immune
cells or pixels and toluidine-stained mast cells were counted
in 203 or 403 images and results were recorded as num-
ber of cells or pixels per image. Primary antibodies for IHC
included rabbit polyclonal antibodies for b-catenin (Ther-
moFisher Scientiﬁc/Lab Vision, Fremont, CA), cleaved
caspase-3, NFj-B-p65 and c-Jun (Cell Signaling, Beverly,
MA), Ki-67 (Cell Marque, Rocklin, CA), and a rat mono-
clonal antibody for Foxp3 (eBioscience, San Diego, CA)
detection. Primary antibody binding was detected with goat
anti-rabbit polymer HRP (ZytoChem Plus, Berlin, Germany)
or biotinylated goat anti-rat IgG (Serotec, Oxford, UK).
Heat-induced antigen retrieval was performed with citrate
buffer, pH 6, for b-catenin, cleaved caspase-3, NFj-B-p65
and c-Jun or with EDTA buffer, pH 8, for ki-67 and Foxp-
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3. The ImageJ image processing and analysis program
(NIH, Bethesda, MD) was used for all quantitative histo-
morphometry assessments.
Statistical analyses
The Mann-Whitney U test was used for body weight, and
histomorphometry. Mammary tumor volume and multiplicity
was evaluated using unpaired student T test. A p value< 0.05
was statistically signiﬁcant.
Results
Outbred Swiss mice eating Westernized ‘fast food’ style
diet have increased risk of mammary preneoplastic lesions
Obesity-inducing diets promote mammary cancer in both
humans and mice.1–6 To recapitulate these observations we fed
genetically outbred Swiss female mice an ad libitum diet of
New Westernized diet (NWD) chow mimicking typical human
“fast food”-style diets that are high in fat and sugar, and low
in ﬁber and vitamins B and D. We examined the mammary
tissues of the 5-month-old mice when fed continuously on
Western (N5 10 animals) and control (N5 10 animals) diets
starting at age5 8 weeks, in order to determine the frequency
and spectrum of diet-induced mammary pathology. We found
that the mammary ducts and terminal duct lobular units of
Westernized chow-fed mice had increased focal, multifocal, or
diffuse hyperplastic lesions of varying severity. Hyperplastic
glands often showed lateral budding, epithelial cell atypia,
increased mitotic ﬁgures and intra-epithelial neoplasia (carci-
noma in situ). Foci of hyperplastic alveoli resembling hyper-
plastic alveolar nodules (HAN) were also evident (Fig. 1). The
evidence of proliferating cells with ki-67-speciﬁc immunohisto-
chemistry conﬁrmed the hyperproliferation of mammary
glands in mice eating Western chow (Fig. 1). Using a semi-
quantitative scoring system (as shown in Fig. 2a), we found
that the mammary pathology score of Westernized chow-fed
mice differed signiﬁcantly (p< 0.001) from that of mice con-
suming control diet (Figs. 1 and 2b).
Western chow-induced mammary preneoplasia leads to
overt mammary neoplasia
To examine the malignant potential of diet-associated mam-
mary preneoplasia and early neoplasia found at Swiss mice at
Figure 1. Effect of diet and L. reuteri supplementation on mammary gland pathology of Swiss mice. Ducts (upper row) and the terminal
duct lobular units (middle row) of westernized diet-fed mice have precancerous epithelial lesions. The mammary intraepithelial neoplasia
cells fill the lumen of the duct and show increased mitoses, and marked pleomorphism. The lesion in mammary alveoli is an atypical
lobule showing histological features of the “hyperplastic alveolar nodules” such as atypical cells, an intermediate grade of anisokaryosis
and light-brown stained lipid pigments. Compare with normal histology of mammary glands from mice consuming control diet or wester-
nized-diet1L. reuteri. The westernized diet-induced hyperproliferative state of mammary gland epithelium can be better appreciated with
ki-67 specific immunohistochemistry. Ki-671 proliferating cell nuclei are numerous in contrast to control-diet or westernized-diet1L. reu-
teri-fed mice. Histopathology: Hematoxylin and eosin. Ki-67: DAB chromogen, Hematoxylin counterstain. Bars: Histopathology550 lm; Ki-
675100 lm.
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5 months of age, we assessed the frequency of mammary
tumors arising in these mice with the progression of age. We
discovered 2-cm diameter mammary tumors (Fig. 2c) arising
in two (2/6; 33%) of 1-year-old Swiss mice on Westernized
chow, but none in their age-matched female Swiss mice con-
suming a control diet (0/20). Overt mammary tumors in
these mice eating Western chow exhibited typical histopa-
thology of high-grade glandular adenocarcinoma (Fig. 2d). In
addition to traditional criteria of high mitotic index and cel-
lular atypia, malignant phenotype of these tumors was further
conﬁrmed by immunohistochemistry proﬁles consistent with
carcinoma (Fig. 2e). The neoplastic cells had an abnormal
b-catenin staining pattern with diffuse cytoplasmic and occa-
sional nuclear stabilization, indicative of dysregulation in the
wnt gene signaling pathway. Proliferating ki-671 neoplastic
cells were numerous throughout mammary tissue (Fig. 2e).
Western diet-associated mammary carcinogenesis occurs
in a mast cell enriched environment
It is widely known that intestinal microbes modulate host
health through activities of CD41 immune cells, at least in
part through interleukin (Il)-6-dependent reciprocal functions
of anti-inﬂammatory Foxp31 regulatory (Treg) cells and
proinﬂammatory T helper (Th) 17 cells. Based upon our
Figure 2. Westernized diet-induced mammary carcinogenesis in Swiss mice. (a) Progression of diet-associated hyperplastic and early neo-
plastic lesions in the mammary glands of 5-months-old Swiss mice. Figures demonstrate the grading system and depict the spectrum of
epithelial histopathology. Note the advancement of hyperplasia and the progressively increased cellular atypia, typified by increased
nuclear sizes and pleomorphism. (b) Statistical analysis of semi-quantified mammary gland histopathology. The y-axis depicts the mean-
6SEM of histopathological scores given in each experimental group. The westernized-diet significantly promotes mammary gland pathol-
ogy, L. reuteri restores it and depletion of CD251 cells neutralizes the L. reuteri beneficial effect. (c) Gross pathology of mammary tumors
(arrow) found in westernized diet-fed Swiss mice with the progression of age. (d) Typical histopathology of diet-associated overt mammary
tumors of aged Swiss mice. Variably sized neoplastic glands grow in cords and nests and have a medium amount of intervening stroma.
Malignant epithelial cells are highly atypical with marked nuclear pleomorphism, increased mitotic figures, including atypical ones (arrow),
and apoptosis. (e) The mammary tumors show immunohistochemical evidence of abnormal b-catenin distribution (left panel). There is loss
of the normal lateral membrane staining pattern, diffuse cytoplasmic and occasional nuclear stabilization (arrow-head). Numerous Ki-671
(proliferating) neoplastic cells are shown in the right panel. (a and d) Hematoxylin and eosin. (e) DAB chromogen, hematoxylin counterstain.
Bars: a and d-right panel525 lm; d-left panel5100 lm; e550 lm.
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previous observations involving inﬂammatory cells and cyto-
kines in mouse models of cancer,12–14 we examined critical
cellular components of the immune system of the 5-month-
old Westernized “fast food”-style Westernized diet-fed Swiss
female mice. At this time-point of neoplastic initiation, we
found that the mammary lymph nodes of NWD-fed mice
had signiﬁcantly fewer Foxp31 cells compared to the
mammary lymph nodes of mice consuming the control diet
(Fig. 3). This result matches our previous ﬁndings regarding
the effect of NWD on the mesenteric lymph node Treg cell
population. In the NWD-fed female Swiss mice, a topograph-
ical association of Foxp31 cells with abnormal mammary
glands was not observed. Abnormal glands, however, were
surrounded by signiﬁcantly (p< 0.0002) increased numbers
of mast cells, as previously shown in mammary carcinoma of
humans and rodent models.29 Consequently, the number of
mast cells in the abnormal mammary epithelium of Wester-
nized chow-eating mice was signiﬁcantly higher from that of
control diet mice, accompanied by sparse Foxp31 Treg cells
(Fig. 3).
Western diet-induced neoplastic features were reduced
after consuming purified L. reuteri organisms
Previous studies have shown that routine dietary intake of
lactic acid bacteria may lower the risk of breast cancer in
women,22,23 and also suppress mammary cancer development
in mice.24–26 This led us to test the effects of L. reuteri con-
sumption in this mouse model of mammary malignancy
(N5 12–15 animals per group). We found that hyperplastic
and pre-neoplastic features were observed in signiﬁcantly
(p< 0.005) lower frequency in animals receiving puriﬁed L.
reuteri ATCC-PTA-647517,27 when adding 3.5 3 105 organ-
isms/mouse/day to their regular drinking water (Figs. 1 and
2b). L. reuteri-induced restoration of glandular epithelium
coincided with a signiﬁcant increase of mammary lymph
node Foxp31 cells and a signiﬁcant reduction of mammary
tissue mast cells to the base-line control-diet levels (Fig. 3).
We next examined whether consumption of L. reuteri
may inhibit Western diet-induced obesity. Accumulating data
speciﬁcally link Westernized diet-induced obesity with mam-
mary cancer occurrence and growth.1–6 Existing data suggest
that immune system-related events may hold the key trigger
role in the complex interplay between growth factors, hor-
mones and adipokine signaling, which connects high fat diet
and obesity with mammary carcinogenesis.11 We found that
5-month-old mice eating NWD and also consuming L. reu-
teri in drinking water were signiﬁcantly leaner than those
mice fed NWD alone (Supporting Information Fig. S1). We
had previously found that while Swiss mice eating L. reuteri
were uniformly slender, their age-matched counterparts eat-
ing L. reuteri and simultaneously treated with anti-CD25
antibody instead rapidly developed morbid obesity and
Figure 3. The L. reuteri anti-neoplastic effect correlates with restoration of control-level Treg and mast cell populations. Western-type diet
induced lesions in the mammary gland correlate with a morphometrically assessed significant decrease of Foxp31 in the mammary lymph
nodes and significant increase of peri-glandular Toluidine Blue-stained mast cells. Dietary supplementation with L. reuteri restores the
immune cell populations along with mammary gland histology at the base-line control diet-matched levels. Foxp3-specific IHC: DAB chromo-
gen, Hematoxylin counterstain. Mast cells: Toluidine Blue stain. Bars550 lm.
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profound abdominal fat pathology during the ensuing 3
months.18 Swiss mice eating L. reuteri also exhibited signiﬁ-
cantly increased anti-inﬂammatory Foxp31 Treg cells and
lower levels of IL-17 protein within lymph tissues draining
the intestinal tract, along with higher levels of IL-10 protein
and lower levels of IL-17 protein in serum, when compared
with matched control mice.18 This suggested that host ability
to recruit properly functioning anti-inﬂammatory Treg cells
and resulting immune homeostasis is essential for protection
from obesity. Following this reasoning, we postulated that
intestinal microbe-activated CD41CD251 Treg cells may
serve to connect obesity with risk for development of cancer
in tissues such as mammary gland.
Anti-neoplastic effect of L. reuteri requires
antigen-educated CD251 host immune cells
Based upon our earlier work linking intestinal bacteria with
mammary glands via recruitment of CD41CD251 immune
cells,13,30 plus other studies showing dietary lactic acid bacte-
ria suppress mammary cancer through immune-system regu-
latory events,24–26 we hypothesized that lactic acid organisms
such as L. reuteri may protect from cancer by favorably bias-
ing the immune system through induction of anti-
inﬂammatory CD41CD251 Treg cells. We tested this using
depletion of CD41CD251 cells via systemic anti-CD25 anti-
body administration in L. reuteri-treated mice (N5 6 ani-
mals). We found that anti-CD25 systemic treatment negated
the beneﬁcial effect of L. reuteri, and resulted instead in
increased mammary hyperplastic and preneoplastic lesions
(Figs. 2b and 4) with an abnormal mammary gland-
associated accumulation (p< 0.002) of mast cells (Fig. 4).
The latter mast cell accumulation effect was also observed in
untreated Westernized diet-fed mice depleted of CD251 cells
and without L. reuteri (Supporting Information Fig. S2). This
result further supports the conclusion that the systemic
CD251 cell population inversely correlates with the mast cell
accumulations in the mammary gland. In sum, the female
mice fed Westernized chow were susceptible to obesity and
mast cell-associated mammary carcinoma that were inhibited
by feeding L. reuteri. The protective effect of consuming L.
reuteri occurred in a CD25 cell-dependent manner.
Mammary tumor development is independent of obesity in
MMTV-neu HER2 transgenic mice
To test whether an obesity component is speciﬁcally required
for cancer-protective beneﬁts of L. reuteri, we next tested L.
reuteri efﬁcacy in mice that do not typically develop age-
associated obesity: an FVB strain erbB2 mutant mouse genet-
ically predisposed to mammary tumors mimicking 30% of
breast cancers diagnosed in women. For these studies, age-
matched HER2/neu mutant mice, that develop tumors with-
out obesity when eating regular chow, were either untreated
or had their drinking water supplemented with L. reuteri.
The study duration allowed mice to reach 1 year of age,
unless these animals were humanely euthanized prematurely
due to a total cumulative mammary tumor burden exceeding
2 cm in diameter. The HER2 transgenic mouse model, unlike
the outbred Swiss mice which were obese, did not require
age-associated obesity in order to spontaneously develop
numerous and large-sized mammary tumors (Fig. 5 and Sup-
porting Information Fig. S3).
Tumor-free survival was increased in HER2 transgenic mice
after eating purified L. reuteri
Knowing that dietary intake of certain lactic acid organisms
was previously shown to lower the risk of breast cancer in
women,22,23 and mammary cancer in mice,24–26 led us to test
the effects of L. reuteri consumption in mouse models of
mammary malignancy. Age-matched HER2/neu mutant mice
were either untreated or had their water supplemented with
L. reuteri ATCC-PTA-647522,33 with live organisms supplied
at a starting dosage of 3.5 3 105 organisms/mouse/day in
drinking water. Mice were euthanized when the total cumula-
tive tumor burden on the animal reached 2 cm in diameter
or when animals reached 1 year of age. We found that treat-
ing with L. reuteri in water delayed or completely prevented
tumor onset when compared with untreated mice (Fig. 5a).
This showed that consumption of lactic acid bacteria alone
was sufﬁcient to inhibit mammary tumorigenesis and
improve tumor-free longevity, even in mice genetically pre-
disposed to cancer, with consumption of lactic acid microbes
counteracting genetic risks.
Apoptosis was upregulated in MMTV-neu mammary tissues
after eating L. reuteri
In addition, we found that key indicators of malignancy were
signiﬁcantly altered in transgenic animals receiving regular
chow in combination with puriﬁed L. reuteri in their drink-
ing water (Fig. 6 and Supporting Information Fig. S4). Mam-
mary tumors of untreated MMTV-neu HER2 mice (N5 10
animals) eating regular diets displayed the typical histopatho-
logical features for this mouse model. Tumors were primarily
solid (Supporting Information Fig. S4) but often had areas
displaying a papillary growth pattern (not shown). In con-
trast to spontaneous tumors of aged Swiss mice on wester-
nized diet, HER2/neu tumors showed no abnormal b-catenin
staining pattern (Supporting Information Fig. S5). Dietary L.
reuteri in HER2 mice (N5 8 animals) did not alter the histo-
pathological pattern of tumor growth or the proliferating
capacity of tumor cells. However, tumors from probiotic-fed
mice had increased areas of intra-tumoral necrosis and
increased features of histopathologically discernible apoptosis.
To quantify apoptosis more accurately we utilized caspase-3
speciﬁc immunostaining. Morphometric counts of apoptosis
showed that tumors from L. reuteri-treated mice had signiﬁ-
cantly (p< 0.0021) more apoptosis compared to tumors from
their nontreated counterparts. To further elaborate on this
result, we examined the tumors for the expression of two
pleiotropic factors with known anti-apoptotic effects on
tumors, including those originating from mammary
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epithelium. Utilizing NFj-B p65- and c-Jun-speciﬁc immu-
nohistochemistry and morphometric counts of positively-
stained cells in comparable (non-necrotic) tumor areas, we
found that L. reuteri induced a signiﬁcant decrease of nuclear
NFj-B (p< 0.0002) and of c-Jun (p< 0.0025) in neoplastic
cells (Fig. 6). Interestingly, tumor cells neighboring to
necrotic areas in tumors from L. reuteri-fed mice had
increased c-Jun expression (Supporting Information Fig. S6).
These data, when combined, suggested that consuming L.
reuteri served to upregulate apoptosis in the tumor prone
mammary tissue.
L. reuteri-treated donor CD41CD45RBloCD251 immune
cells imbued transplantable anti-cancer protection into
HER2 transgenic recipient mice
To identify a cellular mechanism of the beneﬁts of the probi-
otic, and having previously shown a protective role for CD251
cells in Swiss mice, we puriﬁed CD41CD45RBloCD251 cells
Figure 4. The protective effect of L. reuteri depends upon CD251 cells. The depletion of CD251 cells negated the protective effect offered
by L. reuteri in mice consuming the western-type diet. Compare the mammary gland from a CD25 cell-depleted mouse with carcinoma in
situ with the mammary gland from a sham antibody-treated mouse showing only low grade hyperplasia without atypia. The mammary epi-
thelium of sham antibody-treated control mice had occasional Ki-671 proliferating cells (Ki-671 cells in the lymphoid follicle germinal cen-
ter of the mammary lymph node serves as a stain internal positive control). In contrast, CD25 cell-depleted mice had a hyperproliferative
mammary gland epithelium. Mammary gland pathology after CD251 cell depletion co-existed with a significant increase of mast cells. His-
topathology: Hematoxylin and eosin. Ki-67: DAB chromogen, Hematoxylin counterstain. Mast cells: Toluidine Blue stain. Bars: Histo-
pathology525 lm; Ki-675100 lm; Mast cells550 lm.
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from syngeneic FVB wild-type mice that were either untreated
or supplemented with oral administration of L. reuteri in the
drinking water, as above. Afterward, 3 3 105 puriﬁed
CD41CD45RBloCD251 lymphocytes were injected intraperito-
neally into randomly untreated recipient HER2/neu mutant
animals with some pre-existing tumor burden at 6 months of
age. All recipient animals were euthanized at 3–4 weeks after
adoptive cell transfer. We found that transfer of L. reuteri
treated CD41CD45RBloCD251 cells alone was sufﬁcient to
inhibit or suppress mammary tumors when compared with
untreated animals or with animals that received cells from
untreated FVB donor mice. Mice that received L. reuteri treated
CD41CD45RBloCD251 cells had a signiﬁcantly (p< 0.016)
smaller tumor burden and fewer tumors (p< 0.011) compared
with the other treatment groups (Fig. 5b). Taken together, this
was in line with earlier work showing that intestinal bacteria
impact systemic carcinogenic events via recruitment of
bacteria-triggered CD41CD251 immune cells,13,30 and sup-
ported our hypothesis that lactic acid organisms such as L. reu-
teri may protect from cancer by favorably biasing the immune
system through induction of anti-inﬂammatory CD41CD251
regulatory T cells.
Discussion
Here we used two etiologically divergent animal models to
investigate mechanisms of lactic acid microbes previously
shown to impact breast cancer outcomes in women.22,23 In
both mouse models we found that exposure to L. reuteri in
their drinking water ultimately lowered risk of mammary car-
cinogenesis in an immune cell-dependent manner. Impor-
tantly, we show that (i) lower cancer risk outcomes were
achievable in both models using puriﬁed L. reuteri organisms
alone, regardless of the baseline diet, (ii) an environmental
microbial exposure such as L. reuteri was sufﬁcient to inhibit
carcinogenesis, even with a pre-existing genetic predilection
to cancer, and (iii) L. reuteri cancer-protective outcomes
required microbe-triggered CD251 cells. We concluded that
microbes such as L. reuteri may ultimately offer a tractable
public health approach to foster protective immunity and
help counteract the accumulated dietary and genetic carcino-
genic events integral in the Westernized diet and lifestyle.
Outbred Swiss mice consuming a Westernized “fast food”
(NWD) chow mimicked adiposity patterns and associated
breast cancer risk in people,1–6 with lower risk of carcinogen-
esis after consuming L. reuteri. For an outbred strain, the
Swiss mice had a remarkably increased diet-associated risk to
develop pre-neoplastic and neoplastic mammary lesions in
the present study. This risk may not exclusively be related to
the diet. Although control-diet-fed Swiss mice had signiﬁ-
cantly less hyperplasia from westernized-diet fed mice, several
mice of the control group did have some degree of focal or
multifocal mammary gland hyperplasia. These changes,
although mild, are rather unusual based on our empiric
observations in virgin mice of other strains. This matches
Figure 5. Tumor-free survival was increased in HER2 transgenic mice after eating purified L. reuteri. Mice exhibited a delayed onset of mam-
mary tumor burden (a). This anti-cancer protection effect was transplantable using highly purified CD41CD45RBloCD251 immune cells into
HER2 transgenic recipient mice (b).
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previously reported observations in mammary tissue of
untreated FVB mice, an inbred strain closely related to the
white Swiss mouse.31,32 Unlike FVB mice, the aged outbred
Swiss mouse we examined showed no spontaneous mammary
tumors when fed with a normal diet. Nonetheless, the possi-
bility that mouse strain-related factors may contribute to
some extent in the westernized diet-induced mammary
tumorigenesis we report here cannot be excluded.
Hyperproliferative and preneoplastic mammary glands in
NWD-fed mice were surrounded by particularly increased
numbers of mast cells. This is highly suggestive for a cross-
talk between these cells and the proliferating epithelium, and
reminiscent of their accumulation in the expanding terminal
end bud of the mammary ductal system at puberty.33 Mast
cells facilitate abnormal gland growth by extracellular matrix
degradation and the remodeling of adjacent tissues. They also
produce growth factors and cytokines. Studies in both
humans and mice describe signiﬁcant contributions of mast
cells into tumor evolution and development.33–35
Mast cell accumulations were inversely related to the L.
reuteri-induced restoration of the Foxp31 cell population
within mammary lymph nodes. In addition, mast cells were
robustly increased after depletion of CD251 cells. This result
suggests that gut bacteria-triggered CD251Foxp31 Treg cells
can not only inhibit systemic mast cell-associated pathologies,
such as allergy and autoimmune reactions,29 but also early
stage carcinogenesis, as well. Consequently, it supports the
concept that exposures to lactic acid microbiota stimulate
Treg cell-orchestrated immune networks capable of inhibiting
inﬂammatory diseases, including early stage malignant
transformation.35,36
These observations associated with a Western diet in
aging Swiss female mice support a mechanistic model
whereby lactic acid microbes impact host immunity, which in
turn affects obesity and carcinogenesis that subsequently
alters host immunity, and so forth. Once initiated, these
processes may become self-sustaining. We postulate that oral
dosing of L. reuteri imparts immune homeostasis that then
Figure 6. Feeding of L. reuteri increases apoptosis and suppresses anti-apoptotic signals in HER2/neu mammary tumors. Morphometric
counts of immunohistochemically labeled tumors suggest that L. reuteri consumption associates with a significant increase in neoplastic
cell apoptosis (Caspase-31 cells) and a significantly decrease in NFj-B- and c-Jun-derived tumor cell-originating anti-apoptotic signals. DAB
chromogen, Hematoxylin counterstain. Bars: Caspase-3550 lm; NFj-B p65 and c-Jun525 lm.
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maintains systemic immune balance relying upon sustained
immune tolerance. Diet and microbe-induced failure of toler-
ance uniﬁes these data with prior work involving inﬂamma-
tion, obesity, and cancer.18,37 Diverse disorders such as
asthma and autoimmune diseases associated with Wester-
nized living are widely believed to result from insufﬁcient
immune tolerance that is essential for sustained systemic
health. Westernized diets are also low in vitamin D, a nutri-
ent that normally works together with IL-10 to enforce
immune tolerance and protect against inﬂammatory disor-
ders38 and some types of cancer.39
To overcome diet and obesity-associated biases in under-
standing carcinogenesis, we separately tested roles of L. reuteri
and candidate immune cells in slender erbB2 mutant mice,
with a genetic predisposition to mammary tumors mimicking
30% of breast cancers diagnosed in women.15 Our ﬁnding that
mammary tumors from HER2/neu mice consuming L. reuteri
have increased intratumoral necrosis and apoptosis is similar
to our previous ﬁndings in ApcMin/1 mice after adoptive
transfer of microbe-induced Treg cells. Regressive intestinal
adenomas in these ApcMin/1 mice after Treg cell transfer were
characterized by umbilicated necrotic centers and increased
tumor cell apoptosis.37 NFj-B and c-Jun expression of tumor
cells have both been associated with increased tumor malig-
nancy in humans40,41 and mouse models of mammary cancer,
including the HER2/neu mice.42 An important aspect of the
tumor-promoting effect of these pleiotropic proteins lies in
their tumor cell survival and anti-apoptotic effects.43 We
found that dietary L. reuteri blocked NFj-B-p65 nuclear trans-
location and c-jun expression in mammary tumor cells. This
effect may have rendered HER2/neu tumor cells less resistant
to apoptosis, and thus explain, at least in part, the probiotic
microbe-induced anti-neoplastic effect.
It is not entirely clear how host hormones triggered by
microbial symbionts such as L. reuteri may impact the carci-
nogenic processes. We have recently discovered that con-
sumption of L. reuteri up-regulates plasma levels of the
neuropeptide hormone oxytocin17,18,44 that also beneﬁts dam-
aged tissue repairs,44 a concept that may extrapolate from
wound healing to breast cancer.45 It has also been shown
that oxytocin may counteract some of the immune suppres-
sive effects of estrogen.46 These observations, if translatable
to humans, may be particularly important given the proposed
roles of oxytocin in protection from breast cancer.47 In addi-
tion, emerging data relate oxytocin with metabolism and the
immune system46,48 connecting microbial symbionts such as
L. reuteri with immune ﬁtness in evolutionary success.46
Our previous work and that of many others has revealed
that CD41CD251 cells are a basic cellular carrier of gut
microbially triggered signals that shape the immune system to
restore homeostasis in inﬂammatory-associated pathologies,
cancer, and reproductive health.13,49,50 We discovered that the
L. reuteri beneﬁt was transferable to other recipient animals
using CD41CD45RBloCD251 cells alone, as long as those cells
were from immune-competent donor animals. In our previous
studies we have shown that homeostatic properties reside pre-
dominantly in this sub-population of Treg cells.14 In the pres-
ent study transplanted CD41CD45RBloCD251 immune cells
from L. reuteri-primed donor animals were sufﬁcient to com-
pletely recapitulate the L. reuteri-induced phenomenon in
HER2 transgenic recipient host animals. In conclusion, we
found that ingested microbes impact the systemic immune
system at the whole organism level and serve to counteract a
genetic predisposition to cancer, even within the tumor micro-
environment. Beneﬁcial microbes may ultimately offer tracta-
ble population-based approaches to target cancer.
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